AIM
SRGA

Acrospire Investment Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Acrospire Investment Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-228
Closed -$40K – 1668
2017
Q2 		$40K Sell
228
-50
-18% -$7.11K 0.04% 1079
2017
Q1 		$33K Buy
278
+98
+54% +$10.2K 0.03% 1306
2016
Q4 		$18K Buy
+180
New +$16.5K 0.01% 1799
2016
Q3 		– Sell
-180
Closed -$19K – 2233
2016
Q2 		$19K Sell
180
-10
-5% -$1.17K 0.01% 1546
2016
Q1 		$23K Buy
+190
New +$20K 0.02% 1481

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $283M AUM 23.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acrospire Investment Management's SRGA Position: Q3 2017 in Review

Acrospire Investment Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2017, closing a stake of 228 shares — an estimated $40K sold.

Acrospire Investment Management first reported a position in SRGA in Q1 2016 and held it in 5 quarters. The position peaked at $40K in Q2 2017. 103 funds tracked by Wall St. Rank hold SRGA as of Q3 2017.

  • Acrospire Investment Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 228 Surgalign Holdings, Inc. Common Stock shares in Q3 2017, an estimated $40K.
  • Acrospire Investment Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Surgalign Holdings, Inc. Common Stock position peaked at $40K in Q2 2017.
  • 103 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.